智飞生物：公司高度重视研发创新

Group 1 - The company emphasizes its commitment to research and innovation, establishing three major research and production bases: Zhifei Green Bamboo, Zhifei Longke Ma, and Chongqing Chengan, along with an innovation incubation center in Beijing, to achieve a synergistic development of "prevention & treatment" [1] - Currently, several products are in the上市审评阶段, including the human diploid rabies vaccine, quadrivalent meningococcal conjugate vaccine, 15-valent pneumococcal conjugate vaccine, and liraglutide injection [1]